Floatz logo

Tyrosinase-Related Protein-1

Metastatic Mucosal Melanoma

Mayo ClinicvaccinePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

33 Active assets in the Metastatic Mucosal Melanoma cohort.

Asset / SponsorPhaseRating
Pembrolizumab
Melanoma Institute Australia
Phase 3BB
Tyrosinase Peptide
University of Southern California
Phase 3BB
Ifa
Craig L Slingluff, Jr
Phase 2B
INTERFERON ALFA-2B
Shanghai Junshi Bioscience Co., Ltd.
Phase 3B
Polyiclc
Fred Hutchinson Cancer Center
Phase 2B

View all 50 →

Same molecule, other indications

Tyrosinase-Related Protein-1 is also rated in:

cutaneous melanomaDormant
B
Indicative ·
58 / 100
View asset →
malignant choroid melanomaDormant
CC
Indicative ·
43 / 100
View asset →
melanomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →